FIELD: pharmaceutical industry. SUBSTANCE: substance represents hyaluronic acid and allows number of garlic powder intakes to be reduced owing to at least twice prolonged anti-atherogenic effect. EFFECT: prolonged garlic powder efficiency.
Title | Year | Author | Number |
---|---|---|---|
IMMUNOCORRECTIVE AGENT FOR THERAPY OF ATHEROSCLEROTIC DISEASES | 2013 |
|
RU2539133C1 |
APPLICATION FOR TREATING AND PREVENTING ATHEROSCLEROSIS OF PROTEIN-PEPTIDE COMPLEX (HEREINAFTER PPC) OBTAINED FROM EMBRYONIC NERVE TISSUE OR OF QUICK FROZEN EMBRYO BRAIN OF FARM HOOFED ANIMALS AFFECTING CHECK TRANSPORT CHOLESTEROL FROM VASCULAR WALL AND PROFILE OF ACTIVATION OF MONOCYTES IN PATIENTS WITH MANIFESTED ATHEROSCLEROSIS OF GREAT VESSELS OR WITH PREDISPOSITION TO CARDIOVASCULAR DISEASES AND METHOD FOR PREVENTING AND TREATING PATIENTS WITH ARTERIAL ATHEROSCLEROSIS AND DISEASES CAUSED BY ATHEROSCLEROSIS OF MAJOR AND PERIPHERAL VASCULAR CEREBRAL, HEART, AORTA AND LOWER EXTREMITIES (TWO VERSIONS) | 2014 |
|
RU2586286C2 |
METHOD OF TREATING ATHEROSCLEROSIS HAVING ANTI-CYTOKINE ACTION | 2012 |
|
RU2539377C2 |
METHOD FOR PREVENTING AND TREATING ATHEROSCLEROSIS | 2011 |
|
RU2455016C1 |
METHOD FOR PREVENTION OF ATHEROSCLEROSIS BASED ON INHIBITION OF ATHEROGENIC LIPOPROTEIN MODIFICATION | 2011 |
|
RU2484841C1 |
METHOD FOR DETERMINING ATHEROGENIC ACTIVITY OF FOOD PRODUCTS | 2018 |
|
RU2696569C1 |
AGENT "CARINAT" FOR PROPHYLAXIS OF CARDIOVASCULAR AND ONCOLOGICAL DISEASES | 1998 |
|
RU2129874C1 |
HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENT | 2007 |
|
RU2372923C2 |
AGENT WITH HYPOLIPIDEMIC ACTIVITY | 2004 |
|
RU2268714C1 |
AGENT WITH IMMUNOMODULATING PROPERTIES FOR PREVENTION OF ATHEROSCLEROSIS | 2014 |
|
RU2597161C2 |
Authors
Dates
1999-11-27—Published
1998-03-26—Filed